Search - tctmd.com

Displaying 801 - 820 of 1160

Sort: Relevancy | Date

News Daily News

Generic ARBs Linked to Increased Adverse Events

Michael O'Riordan

October 04, 2017

News Daily News

Modified Risk Score for ED Chest Pain Patients Reduces Hospital Stays, Lowers Costs

Michael O'Riordan

October 03, 2017

News Daily News

No Anticoagulation Benefit, High Bleeding Risk Seen in Patients With Secondary A-fib

Michael O'Riordan

September 29, 2017

News Daily News

Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly

Michael O'Riordan

September 27, 2017

News Daily News

Endothelial Dysfunction Observed Following Transradial Catheterization, Meta-analysis Suggests

Michael O'Riordan

September 22, 2017

News Daily News

New Performance and Quality Metrics for STEMI and NSTEMI Care

Michael O'Riordan

September 21, 2017

News Daily News

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

Michael O'Riordan

September 21, 2017

News Daily News

Ischemic Heart Disease the Leading Cause of Death Globally

Michael O'Riordan

September 19, 2017

News Daily News

Frail Patients Benefit From MitraClip, With Gains in Function and Quality of Life

Michael O'Riordan

September 18, 2017

News Daily News

Patients in PCI Trials Vary Around the World, With Women Still Underrepresented

Michael O'Riordan

September 15, 2017

News Daily News

Evolocumab Not Cost-Effective at Current List Price

Michael O'Riordan

August 23, 2017

News Daily News

TAVR in the US: Regional Variations in Numbers, Outcomes

Michael O'Riordan

August 22, 2017

News Daily News

PET More Accurate for Diagnosing CAD Than SPECT and CT Angiography: PACIFIC Study

Michael O'Riordan

August 17, 2017

News Daily News

FDA: Class I Recall for Cook’s Thoracic Endovascular Grafts

Michael O'Riordan

August 17, 2017

Studies Supporting Device Modifications Weak, Often Based on Surrogate Endpoints

News Daily News

FDA Clearance of Modified Devices Relies Heavily on Weak Studies, Surrogate Endpoints

Michael O'Riordan

August 16, 2017

News Daily News

Early Invasive Strategy Benefits Select High-Risk NSTE ACS Patients, Meta-analysis Suggests

Michael O'Riordan

August 14, 2017

News Daily News

Obese Cardiac Surgery Patients a Burden on ICU Resources

Michael O'Riordan

August 11, 2017

News Daily News

Reusing the Radial: Repeat Transradial Access Safe and Feasible, Even Within 24 Hours

Michael O'Riordan

August 09, 2017

News Daily News

Money-Back Guarantee for Evolocumab Has Little Impact on Cost-Effectiveness

Michael O'Riordan

August 08, 2017

News Daily News

CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition

Michael O'Riordan

August 04, 2017

Advertisement

Generic ARBs Linked to Increased Adverse Events

Modified Risk Score for ED Chest Pain Patients Reduces Hospital Stays, Lowers Costs

No Anticoagulation Benefit, High Bleeding Risk Seen in Patients With Secondary A-fib

Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly

Endothelial Dysfunction Observed Following Transradial Catheterization, Meta-analysis Suggests

New Performance and Quality Metrics for STEMI and NSTEMI Care

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

Ischemic Heart Disease the Leading Cause of Death Globally

Frail Patients Benefit From MitraClip, With Gains in Function and Quality of Life

Patients in PCI Trials Vary Around the World, With Women Still Underrepresented

Evolocumab Not Cost-Effective at Current List Price

TAVR in the US: Regional Variations in Numbers, Outcomes

PET More Accurate for Diagnosing CAD Than SPECT and CT Angiography: PACIFIC Study

FDA: Class I Recall for Cook’s Thoracic Endovascular Grafts

FDA Clearance of Modified Devices Relies Heavily on Weak Studies, Surrogate Endpoints

Early Invasive Strategy Benefits Select High-Risk NSTE ACS Patients, Meta-analysis Suggests

Obese Cardiac Surgery Patients a Burden on ICU Resources

Reusing the Radial: Repeat Transradial Access Safe and Feasible, Even Within 24 Hours

Money-Back Guarantee for Evolocumab Has Little Impact on Cost-Effectiveness

CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content